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MHC Class I Molecules Can Direct
Proteolytic Cleavage of Antigenic Precursors
in the Endoplasmic Reticulum
can efficiently generate appropriate peptides, with
strictly defined length and conserved sequence motifs,
without knowledge of which set of polymorphic MHC
molecules await their arrival in the ER. A possible solu-
tion to this conundrum was recently suggested by the
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Department of Molecular and Cell Biology
University of California, Berkeley
Berkeley, California 94720 discovery that cytosolic proteolysis of a model antigenic
protein yielded a mixture of proteolytic intermediates
rather than the single, precisely cleaved peptide that
was ultimately presented by the MHC molecule on theSummary
cell surface (Paz et al., 1999). A subset of these extended
peptides was transported by TAP into the ER in this andThe large set of peptides presented by MHC (major
in another recent study (Lauvau et al., 1999). Intriguingly,histocompatibility complex) class I molecules are gen-
the yields of the extended precursor and that of theerated by proteolysis of diverse precursors in the cyto-
optimally trimmed peptide were inversely proportionalplasm and possibly in the endoplasmic reticulum (ER).
and were dramatically influenced by the presence ofTo define the potential peptide trimming events in the
the appropriate MHC molecule (Paz et al., 1999). TheseER, we analyzed proteolytic products generated in iso-
findings suggested the existence of a precursor/productlated microsomes. The residues flanking the N termi-
relationship between the extended and optimally cleavednus of the final antigenic peptide were rapidly removed
peptides that was somehow influenced by the MHCwithin the microsomes but only in the presence of
molecules. They also provided an explanation for earlierappropriate MHC molecules. Remarkably, the precur-
reports which had shown that naturally processed pep-sor peptide was bound to the MHC molecules in a
tides were detected only in the presence of appropriatedistinct conformation and required an aminopeptidase
MHC molecules (Falk et al., 1990; Malarkannan et al.,activity to generate the optimal peptide. The MHC mol-
1995). Furthermore, the evidence for the inverse relation-ecules are therefore not only the final repositories of
ship between the MHC dependent recovery of the pre-antigenic peptides, but they can also direct their exci-
cursor and its peptide products supported the originalsion from longer precursors.
hypothesis of the Rammensee group, which suggested
that MHC molecules may also direct the generation ofIntroduction
the optimally cleaved antigenic peptides that they sub-
sequently display on the cell surface (Falk et al., 1990).Cytotoxic T cells detect abnormal intracellular events
The most attractive feature of this model was that itby the presence of unique peptides displayed by MHC
relieved the cytosol of the sole responsibility of generat-(major histocompatibility complex) class I molecules
ing the large sets of precisely cleaved peptides required(Falk et al., 1991; Madden et al., 1991). These peptides
by the ER-resident polymorphic MHC molecules (Ram-are generated by fragmentation of the diverse pool of
mensee et al., 1995). Rather, the model postulated thatnewly synthesized intracellular proteins (Rock and Gold-
antigenic precursors were fragmented not only in theberg, 1999; Reits et al., 2000; Schubert et al., 2000). The
cytosol, but also in the ER where the final peptide trim-peptide/MHC complex thus represents the convergence
ming events could be efficiently guided by the MHCof two independent pathways: one for generating pep-
molecules (Paz et al., 1999).tide-receptive MHC molecules, and another for generat-
Our attempts to test this hypothesis and to defineing candidate peptides for potential binding to the MHC.
how the MHC molecules determined the outcome of thePeptide-receptive MHC molecules are generated in the
antigen processing reactions, however, failed in livingendoplasmic reticulum (ER) by mechanisms involving
cells. The failures were due to (1) the high complexitygeneral housekeeping components, such as the chaper-
of the mixture of proteolytic intermediates generated inones calnexin and/or calreticulin, that enable proper
living cells, which made it difficult to study precursor/folding of the MHC subunits as well as specialized com-
product relationships, and (2) an inability to selectivelyponents, such as tapasin, which tethers the empty MHC
inhibit the ER trimming reactions in living cells to capturemolecules to the TAP transporter (Cresswell et al., 1999).
putative reaction intermediates. To overcome these dif-On the other hand, antigenic precursors are degraded
ficulties, we developed a novel in vitro model for analysisin the cytosol, primarily by the multicatalytic proteosome
of peptide trimming reactions in murine microsomes.and possibly other proteases (Rock and Goldberg, 1999;
The microsomes have previously been established as aStoltze et al., 2000). The peptide fragments are then
model for the study of selective peptide transport bytransported by TAP into the ER where they can be tested
TAP (Neefjes et al., 1993; Shepherd et al., 1993; Mom-for their ability to bind the available MHC molecules.
burg et al., 1994; van Endert et al., 1994) and peptideThe topological separation between the sites for pep-
binding molecules (Marusina et al., 1997; Spee andtide generation in the cytosol and MHC loading in the
Neefjes, 1997). Using a natural TAP substrate and aER raises the dilemma of how cytosolic proteolysis alone
highly sensitive assay to detect proteolytic intermedi-
ates, we show here that antigenic peptides are trimmed2 Correspondence: nshastri@socrates.berkeley.edu
in the microsomes by an aminopeptidase and that the3 Present address: The Netherlands Cancer Institute, Division of Im-
munology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. MHC molecules can direct this process.
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Figure 1. Activity of the N-Terminally Extended SHL8 (SIINFEHL) Analogs K-SHL8 and LK-SHL8 is Greatly Enhanced by Trypsin Treatment
Varying concentration of synthetic SHL8, K-SHL8, and LK-SHL8 peptides were tested (a) as such or (b) after treatment with trypsin to stimulate
SHL8/Kb-specific B3Z T cell hybridoma. Kb-L cells were used as antigen-presenting cells (APC). After overnight incubation, the lacZ response
of B3Z T cells was assayed as the -galactosidase activity by the conversion of the substrate chlorophenol red -D-pyrannoside measured
at 595 nm.
Antigenic peptide activity can be recovered from microsomes after TAP- and ATP-dependent transport and in presence of appropriate Kb/Db
MHC class I molecules. SHL8/Kb-specific B3Z T cell response to dilutions of total microsomal extracts after incubation with C57BL/6 microsomes
and 50 fmol of (c) SHL8, (d) K-SHL8, and (e–h) LK-SHL8 peptides in the absence (c) or presence of ATP (J). B3Z T cell responses to total
extracts prepared after incubation of the LK-SHL8 peptide with microsomes prepared from (f) TAP/, (g) B10.A(5R), and (h) B10.D2 mice.
The presence of the relevant Kb and Db MHC class I molecules in the microsomes is indicated. All samples were treated with trypsin before
the assay to release the optimally active SHL8 peptide from the extended precursor (Paz et al., 1999). Kb-L cells were used as APC, and the
antigen-specific B3Z T cell response was measured as above.
Results & Discussion (SIINFEHL, SHL8) peptide, LK-SIINFEHL (LK-SHL8), was
used as a precursor because we had earlier shown that
this peptide was a natural substrate for TAP transloca-In Vitro Model for Peptide Trimming in the ER
To determine if trimming of antigenic peptides occurred tion in intact cells (Paz et al., 1999). Most importantly,
because the LK-SHL8 peptide contains a single lysinein the ER, we developed an in vitro model for antigen
processing in murine microsomes. An N-terminally ex- (K) residue flanking the SHL8 peptide, treatment of LK-
SHL8 or the K-SHL8 peptides with trypsin, whichtended version of the naturally processed OVA257-264
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Figure 2. Precursor Peptides Trimmed to Optimal MHC Binding Peptides within the Microsomes
Acid extracts prepared from (a–c) C57BL/6 and (d) B10.A(5R) microsomes after incubation with (a) SHL8, (b) K-SHL8, or (c–e) LK-SHL8 peptides
were fractionated by HPLC and assayed for B3Z T cell stimulating activity as in legend to Figure 1. (e) The entire reaction mixture was extracted
after incubation of the TAP/ microsomes with the LK-SHL8 peptide. All HPLC fractions were treated with trypsin before the assay to release
the optimally active SHL8 peptide from the extended precursor. Arrows mark the peak HPLC retention time of the indicated synthetic peptides
run and assayed under identical conditions.
cleaves at the carboxy terminus of lysines, releases the with microsomes from TAP-deficient mice (Figure 1f)
(Neefjes et al., 1993; Shepherd et al., 1993). Most signifi-optimally active SHL8 peptide (Figures 1a and 1b). This
100- to 1000-fold increase in activity makes it possible cantly, the antigenic activity was detected in microsomal
extracts only when the appropriate MHC moleculesto detect these poorly antigenic N-terminally extended
analogs of the SHL8 peptide in complex extracts using were also present in the microsomes prepared from the
C57BL/6 (Kb, Db) or the B10.A(5R) (Kb) mice, but not fromthe standard SL8/Kb-specific B3Z T cell activation assay.
Furthermore, when the extracts were first fractionated the B10.D2 (H-2d) mice (Figures 1g and 1h). Presently,
it is unclear why the precursor LK-SHL8 peptide wasby HPLC and the fractions were treated with trypsin
prior to the T cell assay the conversion of the LK-SHL8 not recovered from the B10.D2 microsomes that lack
the relevant Kb or Db MHC molecules. It is possible thatand K-SHL8 peptides into SHL8 revealed their presence
as well as their identity as activity peaks that reproduci- the peptide was rapidly degraded (Paz et al., 1999) or
was fluxed out of the microsomes (Schumacher et al.,bly elute in characteristic fractions (Paz et al., 1999).
We first tested whether LK-SHL8 and its proteolytic 1994; Koopmann et al., 2000). Another possibility is that
the LK-SHL8 may have been bound to ER chaperones,products K-SHL8 and SHL8 could serve as substrates
for TAP transport in vitro in isolated murine microsomes. such as gp96 (Srivastava et al., 1998), and could have
remained inaccessible to the extraction procedure. TheThe “SHL8” antigenic activity was recovered after incu-
bating the peptides with microsomes from C57BL/6 (B6) latter possibility is, however, rendered less likely be-
cause the association of the LK-SHL8 peptide with themice in the presence of ATP (Figures 1c–1e) but not
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chaperones would have to be resistant to a harsh 5 min
incubation with 10% formic acid at 95C.
To determine if the antigenic activity recovered from
the microsomes represented the input peptides them-
selves or their proteolytic products, the microsomes
were isolated from the reaction mixture by a spin through
a sucrose cushion and were extracted with acetic acid.
The microsomal extracts were then fractionated by re-
verse phase HPLC, and the fractions were analyzed for
presence of T cell-activating peptides after trypsin treat-
ment. The activity profiles showed that while the input
SHL8 peptide was recovered as such, the N-terminal
residues of both the K-SHL8 and LK-SHL8 peptides
were trimmed to yield the optimal SHL8 octapeptide
(Figures 2a–2c). The LK-SHL8 decapeptide also yielded
the K-SHL8 nonapeptide in Kb and Db containing B6
microsomes, but not in B10.A(5R) microsomes which
contain only Kb MHC (Figure 2d). This result is consistent
with the previous demonstrations that the SHL8 and
K-SHL8 peptides bind optimally to Kb and Db MHC, re-
spectively (Buchholz et al., 1995; Malarkannan et al.,
1995). Generation of SHL8 and K-SHL8 occurred within
the microsomes because the trimmed peptides were
not detected when the LK-SHL8 precursor was incu-
bated with the TAP/ microsomes in the presence of
ATP and the entire mixture was extracted and analyzed
by HPLC (Figure 2e). Furthermore, consistent with their
Figure 3. Microsomal Trimming of LK-SHL8 Peptide Is Blocked by
lumenal location, the peptide recovery was not inhibited Aminopeptidase Inhibitors
by proteinase K treatment of the microsomes (Paz et al.,
B3Z T cell responses to HPLC fractionated extracts of C57BL/6
1999; data not shown). We conclude that, as observed microsomes after incubation with LK-SHL8 peptide in (a) the ab-
earlier in intact cells (Paz et al., 1999), within isolated sence or (b and c) presence of aminopeptidase inhibitors Leuci-
nechloromethylketone (LCMK) or bestatin. HPLC fractions were an-microsomes an N-terminally extended precursor pep-
alyzed as in legend to Figure 2. The arrows indicate the peaktide was transported via TAP, and its optimally trimmed
retention times of the indicated peptides shown in part (a).products were recovered only in the presence of the
relevant MHC molecules.
The requirement for the MHC molecules in allowing peptide. Inhibitors of cysteine-proteases (FK029 and
the recovery of optimally cleaved peptides in this in vitro E64), of serine proteases (dichloroisocoumarin), and of
model is similar to what has been consistently observed proteasomes (LLnL and lactacystin) did not significantly
in intact cells (Falk et al., 1990; Malarkannan et al., 1995; affect the cleavage of LK-SHL8 in the microsomes (data
Paz et al., 1999). However, whether this outcome was not shown). These results implicated an aminopepti-
due to the requirement of MHC molecules to stabilize dase(s) in the peptide trimming reaction.
the optimally cleaved peptides or was due to an active Second, we modified the in vitro cleavage reaction in
role for the MHC in the peptide trimming reactions has which the peptide was added to permeabilized rather
remained difficult to resolve in intact cells. A key predic- than intact microsomes. This critical modification made
tion of the latter hypothesis is that a longer precursor it possible to decrease the incubation temperature and
should be associated with the MHC molecules as an time, which otherwise dramatically reduced peptide
intermediate for the generation of the final peptide/MHC translocation and consequently the yield of trimmed
complex. Because such an intermediate has never been peptides in intact microsomes. The cleavage of LK-
observed in intact cells, we searched for its existence SHL8 precursor peptide to its final SHL8 product in Kb-
in this readily manipulated in vitro model system. expressing B10.A(5R) microsomes occurred rapidly and
was essentially complete in 10 min at 10C or just 2 min
at 37C (Figures 4c and 4e). Decreasing the incubationPeptide Trimming in the Microsomes Requires
Aminopeptidase Activity and Occurs Rapidly temperature to 0C partially blocked peptide trimming
(Figures 4a and 4d). Addition of the aminopeptidaseTo detect this elusive intermediate, we initially optimized
conditions in which peptide trimming could be blocked. inhibitors LCMK or bestatin under these conditions also
inhibited peptide cleavages, as was observed with theFirst, we tested a panel of protease inhibitors for their
ability to block the generation of SHL8 and K-SHL8 prod- intact microsomes above (data not shown).
Third, we also tested whether the presence of an ex-ucts from the LK-SHL8 precursor in B6 microsomes
(Figures 3a–3c). Inclusion of the aminopeptidase inhibi- cess of a Kb binding peptide in the reaction could inhibit
peptide trimming. We compared the amount of SHL8tor leucine chloromethylketone (LCMK) during the incu-
bation completely inhibited peptide trimming, whereas peptide recovered from B10.A(5R) microsomes incu-
bated with the LK-SHL8 peptide in the presence of an-another aminopeptidase inhibitor (bestatin) specifically
inhibited the generation of the K-SHL8 but not the SHL8 other Kb binding SFV8 or the irrelevant control NP pep-
Peptide Trimming on the MHC Template
99
Figure 4. Trimming of LK-SHL8 (LK-) to K-SHL8 (K-) or SHL8 (-) within the Microsomes Occurs Rapidly and Is Temperature Dependent
B3Z T cell response to HPLC fractions of permeabilized B10.A(5R) microsomes extracted after incubation with the LK-SHL8 peptide (a–c) for
2 min or (d–f) for 10 min at either 0, 10, or 37C. Processing of LK-SHL8 within microsomes was inhibited by Kb binding peptides. B3Z T cell
response to HPLC fractionated extracts of permeabilized B10.A(5R) microsomes incubated with LK-SHL8 and excess of the (g) Db binding
NP peptide, or the (h) Kb binding SFV8 peptide. HPLC fractions were analyzed as in Figure 2.
tide (Figures 4g and 4h). The yield of the SHL8 peptide subsequent experiments, we determined that the 5F1,
EH144, and 28.8.6S (but not Y3 and AF6) monoclonalswas 0.85 fmol in presence of the SFV8 peptide compared
yielded the LK-SHL8 peptide in the immunoprecipitateto 2.3 fmol recovered in the presence of the NP peptide,
(Figures 5d and 5e; data not shown), although all thewhich represents approximately 65% inhibition of the
tested monoclonals recognized the mature Kb moleculescleavage reaction. This result supports the notion that
on the cell surface and precipitated Kb from lysates ofthe Kb peptide binding site was required for the genera-
metabolically labeled cells (data not shown). Direct evi-tion of SHL8. Together, these data indicate that peptide
dence that both 5F1 and Y3 mAb were equivalent in theirtrimming was a rapid reaction which could nevertheless
ability to immunoprecipitate the final SHL8/Kb complexbe inhibited by lowering the incubation temperature,
was obtained by comparing the Kb bound peptides whendecreasing the incubation time, and including certain
the microsomes were incubated with the LK-SHL8 pre-aminopeptidase inhibitors.
cursor without protease inhibitors at room temperature
to allow the reactions to proceed to completion. In con-
LK-SHL8/Kb Complex Can Be Immunoprecipitated trast to the differential recovery of the LK-SHL8 peptide
from Microsomes observed above (Figures 5d and 5e), immunoprecipi-
To determine if the precursor peptides were bound to tates of B10.A(5R) microsomes with either 5F1 or Y3
the MHC molecules when their proteolysis was inhibited, yielded the SHL8 peptide (Figures 5f and 5g). Again, no
the Kb MHC molecule was immunoprecipitated with a activity was detected in the immunoprecipitates from
panel of antibodies and the eluted peptides were ana- B10.A(4R) mice, demonstrating that the SHL8 peptide
lyzed after HPLC fractionation (Figures 5a–5c). Remark- was specifically bound to the Kb MHC (Figures 5h and 5i).
ably, the LK-SHL8 precursor was found in the material It is interesting that 5F1 and EH144 but not Y3, AF6,
immunoprecipitated with a mixture of anti-Kb mono- or the anti-tail antiserum permitted the isolation of the
clonal antibodies (Figure 5b) but not with antibodies LK-SHL8/Kb complex. The epitopes recognized by Y3,
specific for an epitope in the cytoplasmic tail of Kb (Fig- 5F1, and EH144 have been mapped to opposite ends
ure 5c). No antigenic activity was detected in the immu- of the peptide binding groove containing the carboxy-
noprecipitates of LK-SHL8 incubated with B10.A(4R) mi- termini (Y3) and the amino-termini (5F1, EH144) of the
crosomes (Figure 5a) despite the fact that two of the bound peptide, respectively (Ajitkumar et al., 1988). Be-
anti-Kb monoclonals (5F1 and Y3) also crossreact with cause the LK-SHL8 peptide is likely to extend outside
the Kk MHC molecule expressed by these mice (Jones the Kb peptide binding groove at its N terminus, it was
surprising that the N terminus specific 5F1 mAb ratherand Janeway, 1981; Sherman and Randolph, 1981). In
Immunity
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Figure 5. The LK-SHL8 (LK-) Precursor is Bound to Kb MHC in a Distinct Conformation
B3Z T cell responses to HPLC fractionated peptides eluted from immunoprecipitates prepared from LK-SHL8 incubated with permeabilized
(a) B10.A(4R) or (b–e) B10.A(5R) microsomes. (a and b) A mixture of anti-Kb monoclonal antibodies, (c) an anti-Kb tail specific antiserum, or (d
and e) single anti-Kb monoclonal antibodies indicated were used for the immunoprecipitation. HPLC fractions were analyzed as in Figure 2.
Both 5F1 and Y3 can immunoprecipitate the SHL8/Kb complex from (f and g) B10.A(5R), but not (h and i) B10.A(4R) microsomes that were
incubated with the LK-SHL8 precursor in the absence of inhibitors. The immunoprecipitates were extracted, fractionated by HPLC, and
analyzed as in Figure 2. The arrows indicate the peak elution times of the indicated peptides in the top panels.
than the C terminus specific Y3 mAb should react with Alternatively, it is possible that the tail epitope of LK-
SHL8 bound Kb MHC may have been simply inaccessiblethe LK-SHL8/Kb complex. However, because LK-SHL8
is bound relatively weakly to the Kb molecules on the to the antibodies as was observed earlier for nascent
Kb in pulse-chase analysis of intact cells (Song et al.,cell surface (data not shown), it is possible that only
the N terminus-specific antibodies (5F1 and EH144) can 1994). We conclude that the LK-SHL8 precursor peptide
was specifically bound to Kb MHC in the microsomes instabilize this complex sufficiently to allow its isolation.
This would also explain why the anti-Kb tail antibody a conformation distinct from that of mature Kb containing
the optimally cleaved SHL8 product.failed to immunoprecipitate the LK-SHL8/Kb complex.
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Figure 6. The LK-SHL8/Kb Complex is Transient and is Trimmed to the SHL8/Kb Product
B6 microsomes were incubated with the LK-SHL8 precursor in the (a and b) presence of suboptimal 100 M LCMK concentration or (c and
d) absence of the inhibitor for either 1 or 10 min. The material immunoprecipitated with 5F1 anti-Kb monoclonal was extracted and analyzed
after HPLC fractionation as in Figure 2. The arrows indicate the peak elution times of the peptides indicated in the top panels.
Kb Bound LK-SHL8 Precursor Is Trimmed contrast to the undepleted microsomes where the LK-
SHL8 peptide was readily trimmed to its K-SHL8 andto the SHL8 Product
To determine if the LK-SHL8 precursor peptide bound SHL8 products, only the intact LK-SHL8 peptide was
recovered from the depleted microsomes (Figures 7ato Kb MHC served as an intermediate for generation of
the final SHL8 peptide/Kb complex, we carried out the and 7b). Western blot analysis confirmed that depletion
of the lumenal proteins in the microsomes caused apeptide trimming reactions in the presence of subopti-
mal inhibitor concentration. Microsomes from B6 mice dramatic reduction in the soluble gp96 but not in the
membrane-bound Kb or calnexin proteins (Figure 7c).were lysed with detergent and incubated with the LK-
SHL8 precursor peptide in the presence of 100 M The Kb molecules in the depleted microsomes were nev-
ertheless capable of binding peptides as judged by theLCMK inhibitor, and the Kb bound peptides were ana-
lyzed after immunoprecipitation with the anti-Kb mAb, presence of antigenic peptide in the anti-Kb immunopre-
cipitates (Figures 7d and 7e). Again, this activity was5F1 (Figure 6). In contrast to the Kb immunoprecipitated
from microsomes in presence of 1 mM LCMK (Figure recovered only from the Kb-expressing B10.A(5R) micro-
somes and not those from B10.A(4R) microsomes lack-5d), these Kb molecules contained both the LK-SHL8
precursor as well as a substantial amount of the SHL8 ing Kb MHC, ruling out nonspecific associations with
other microsomal components. We conclude that deple-product peptides consistent with partial inhibition of the
trimming reaction (Figure 6a). However, after 10 min the tion of the lumenal content of the microsomes abrogates
the activity of protease(s) responsible for trimming theanti-Kb immunoprecipitates contained negligible amount
of LK-SHL8 and only the SHL8 product was detectable N-terminal flanking residues of the antigenic precursor
peptide. The data, however, do not allow us to distin-in the extract (Figure 6b). Again, in the absence of the
LCMK inhibitor, only the SHL8 product (but no LK-SHL8) guish whether the loss of trimming activity was due to
depletion of a soluble protease, an essential cofactor,was detected in the anti-Kb immunoprecipitates (Figures
6c and 6d). This result argues strongly against the possi- or was due to denaturation of a membrane-bound mole-
cule under these conditions.bility that the LK-SHL8/Kb complex was a “sink” for the
LK-SHL8 peptide, and provides further evidence that The generation of all known peptides presented by
MHC class I molecules requires the removal of boththe LK-SHL8/Kb complex can serve as a substrate for the
aminopeptidase that yielded the final SHL8/Kb complex. N- and C-terminal flanking residues from their precursor
polypeptides (Rammensee et al., 1995). Some of these
peptides may be generated in the cytosol itself by thePeptide Trimming but Not MHC Binding Is Inhibited
in Depleted Microsomes proteasome in concert with two recently described cyto-
plasmic proteases (Stoltze et al., 2000). There is, how-To further characterize the proteolytic activity responsi-
ble for the removal of the N-terminal flanking residues, ever, compelling evidence that the C termini of most
antigenic peptides are generated in the cytosol by thewe depleted microsomes of their lumenal content by
treatment at high pH (Hamman et al., 1998) and tested proteasome (Craiu et al., 1997; Rock and Goldberg,
1999; Serwold and Shastri, 1999), and these N-terminallythem for their ability to trim the LK-SHL8 peptide. In
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Figure 7. Cleavage of LK-SHL8 to the K-SHL8 (K-) and SHL8 (-) Products is Blocked by Depletion of Lumenal Content of the Microsomes
B3Z T cell responses to HPLC fractionated peptide extracts recovered from LK-SHL8 incubated for 5 min at RT with permeabilized C57BL/6
microsomes which were either used (a) undepleted or (b) after depletion of their lumenal content as described in Experimental Procedures.
(c) Depletion of lumenal content of microsomes correlates with dramatic reduction in the amount of soluble gp96 protein relative to the
membrane-bound calnexin and Kb proteins detected by Western blotting. (d and e) B3Z T cell responses to HPLC fractionated peptides eluted
from anti-Kb immunoprecipitates prepared from SHL8 incubated with microsomes that were (d) undepleted or (e) depleted of their lumenal
content. Microsomes were from B10.A(5R) (J) or B10.A(4R) (P) mice. HPLC fractions were analyzed as in legend to Figure 2.
extended peptides are selectively transported by TAP optimal MHC class I binding epitopes. Most importantly,
they can explain how the antigen-processing pathwayinto the ER (Heemels and Ploegh, 1995; Neefjes et al.,
efficiently generates thousands of different peptides1995; Van Endert et al., 1995; Androlowicz and Cress-
that fit exactly within the antigen binding grooves of thewell, 1996; Paz et al., 1999), where there is little, if any,
MHC class I molecules.carboxypeptidase activity (Powis et al., 1996; Craiu et
al., 1997; Yellen-Shaw et al., 1997; Serwold and Shastri,
Experimental Procedures1999). Our finding that N-terminal flanking residues can
be removed in the ER—in an MHC-dependent man- Cells, Antibodies, Peptides, and T Cell Activation Assays
ner—allows the MHC molecules to “customize” the avail- The SHL8/Kb-specific, lacZ-inducible, B3Z T cell hybridoma K89B7
able peptide pool. We suggest that the ER trimming (Kb and B7.2-expressing L cells); synthetic peptides LK-SIINFEHL
(LK-SHL8), K-SHL8, and SHL8; and T cell activation assays to ana-mechanism involves intermediate complexes of N-ter-
lyze antigenic activity in HPLC fractionated cell extracts have beenminally extended peptides bound to the MHC molecule,
described (Karttunen et al., 1992; Shastri and Gonzalez, 1993; Pazwhich serve as substrates for a microsomal protease(s).
et al., 1999). Monoclonal anti-Kb antibodies EH.144, Y3, 5F1.2.14,
The transient nature of this complex, the rapid rate of 28.8.6S, and AF6.88.5.3 were a kind gift of Dr. S. Nathenson or were
trimming, and the lack of sensitive assays for detecting obtained from ATCC. Polyclonal rabbit anti-Kb tail antiserum was a
kind gift of Dr. E. Song (Song et al., 1994). Western blots wereextended versions of MHC bound antigenic peptides
performed according to standard procedures using anti-gp96, anti-explain why this complex was not detected earlier. Our
Kb tail antiserum, and anti-calnexin antibodies (Stressgen).data strongly support the earlier hypotheses (Falk et al.,
1990; Malarkannan et al., 1995; Paz et al., 1999) that Preparation of Microsomes
MHC class I molecules serve as templates for guiding Microsomes were prepared from C57BL/6 (H-2b), B6.129Tap1tm1Arp
(TAP1/), B10.A(5R) (Kb, Dd, Ld), B10.A(4R) (Kk, Db), and B10.D2 (H-2d)a yet unknown ER aminopeptidase(s) to generate the
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mice obtained from the Jackson Laboratories according to earlier of LK-SHL8 peptide. The reaction was incubated at RT for 5 min
and analyzed as above after extraction.protocols (Walter and Blobel, 1983), with the modifications de-
scribed by Shepherd (Shepherd et al., 1993). Briefly, mice were
injected intraperitoneally with 0.2 mg polyinosinic-polycytidylic acid Immunoprecipitations
(Sigma) 36 hr before sacrifice. Spleens and livers were removed and Fifty microliters of permeabilized microsomes was incubated on ice
collected in a beaker on ice. The organs were washed with ice-cold with 500 fmoles of LK-SHL8 precursor and the protease inhibitors
buffer A (50 mM triethanolamine, 50 mM KOAc [pH 7.5], 250 mM LCMK (100 M or 1 mM) and bestatin (0.6 mM) for 1 min or at RT
sucrose, 6 mM MgOAc, 1 mM dithiothreitol, 0.5 mM phenylmethyl- for indicated time. The reaction was diluted by the addition of anti-
sulfonyl fluoride, 0.027 U/ml aprotinin, 1mM EDTA [pH 7.5]) to re- Kb antibodies bound to protein A/G-sepharose in TBS-0.25% NP40.
move blood. All subsequent steps were performed on ice or at 4C. After 1 hr at 4C, the beads were washed four times with TBS-0.05%
The organs were weighed and 3–4 ml of buffer A was added per NP-40 with or without the inhibitors. Peptides associated with the
gram of tissue. The tissue was minced and homogenized using a immunoprecipitated material were extracted at 95C with 500 l
motor-driven Potter-Elvehjem teflon tissue grinder (chamber clear- 10% formic acid containing 2–10 M of an irrelevant peptide as a
ance 0.1 mm) at half maximal speed with five passes up and down carrier and analyzed after HPLC fractionation and trypsin treatment
of 10 s each. The homogenate was subjected to differential centrifu- of the fractions as described (Paz et al., 1999).
gation steps as described. The homogenate was centrifuged at
1000  g for 10 min to pellet nuclei. The floating fatty material was Depletion of Lumenal Proteins from Microsomes
removed by aspiration. The homogenate was then spun for 10 min Lumenal proteins were depleted from the microsomes as described
at 10,000  g to pellet the mitochondrial fraction. The supernatant (Hamman et al., 1998). Briefly, 50 l microsomes were diluted with
was collected and loaded onto a sucrose-cushion (1.3 M sucrose 50 l 0.1 M triethanolamine (pH 7.5), 400 mM sucrose, and 2 mM
in buffer A) and centrifuged at 140,000  g for 2 hr. The pellet was DTT on ice. One hundred microliters of 0.5 M HEPES, 0.5 M CAPS
resuspended in buffer B (50 mM HEPES, 250 mM sucrose, 1 mM (pH 10.5) was then added, followed by 800 l ice-cold H2O. The
dithiothreitol [pH 7.3]). Crude microsomes were snap-frozen in 25 l dilute microsome suspension was incubated for 20 min and overlaid
aliquots and stored at 70C. Aliquots were used only once after onto a 200 l cushion of 0.5 M sucrose in 50 mM HEPES (pH 7.5),
thawing. 5 mM MgCl2, and 40 mM KOAc. Membranes were collected by
centrifugation in a TLA100.2 rotor (Beckman) for 20 min at 60,000
In Vitro Peptide Translocation Assay rpm. Lumen-extracted microsomes were resuspended in 50 l of
In vitro peptide translocation assays were performed in 100 l reac- 50 mM HEPES (pH 7.5), 200 mM sucrose, and 1 mM DTT. Ten
tions in transport buffer (50 mM HEPES [pH 7.5], 150 mM KOAc, 5 microliters of these extracted microsomes were permeabilized in
mM MgOAc, 250 mM sucrose, 1 mM DTT) with or without ATP (50 10 l PBS-0.5% NP-40 for the in vitro cleavage reactions. To com-
M) and ATP regenerating system (2.5 mM phosphocreatine [Sigma] pensate for any loss, 100 ng of recombinant 2-microglobulin was
and 0.05 U/ml of creatine-phosphokinase) (Shepherd et al., 1993; added to the depleted “open” microsomal preparations.
Paz et al., 1999). Synthetic peptide (50–100 fmol) was added fol-
lowed by the microsomes (5 l, 10–50 g of protein). The reactions Acknowledgments
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